Recent research has highlighted the role of FGFR1 signaling as a pivotal regulator of inflammation, implicating its involvement in numerous chronic inflammation-related disorders, such as cancer (Chen et al., 2020; Wang et al., 2020). Here, FGFR1 is linked to cancer.